// App-Quantinova.ai

2989 : An Intact G1/S checkpoint determines response to CDK4/6 inhibitor in breast cancer

Researchers

Presenter

  • Smruthi Vijayaraghavan

Principal Investigators

  • Khandan Keyomarsi

Medical Centers

  • The University of Texas MD Anderson Cancer Canter, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Neutropenia

  • Solid malignancies

Biomarkers

  • Cyclin-dependent kinase 4

Drug/Treatment

  • Palbociclib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved